{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:45:26Z","timestamp":1776408326757,"version":"3.51.2"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005242","name":"Heed Ophthalmic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ophtha.2019.10.036","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T19:52:17Z","timestamp":1572897137000},"page":"535-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Pentosan Polysulfate Sodium Exposure and Drug-Induced Maculopathy in Commercially Insured Patients in the United States"],"prefix":"10.1016","volume":"127","author":[{"given":"Cassie A.","family":"Ludwig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Vail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia F.","family":"Callaway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malini V.","family":"Pasricha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darius M.","family":"Moshfeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ophtha.2019.10.036_bib1","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ophtha.2019.10.036_bib2","first-page":"159","article-title":"[Thrombocid: a new synthetic anticoagulant]","volume":"59","author":"Frileux","year":"1951","journal-title":"Presse Med"},{"issue":"10","key":"10.1016\/j.ophtha.2019.10.036_bib3","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ophtha.2019.04.024","article-title":"Strength of association between pentosan polysulfate and a novel maculopathy","volume":"126","author":"Hanif","year":"2019","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ophtha.2019.10.036_bib4","first-page":"1545","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment","volume":"193","author":"Hanno","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.ophtha.2019.10.036_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00404-017-4364-2","article-title":"Etiology, pathophysiology and biomarkers of interstitial cystitis\/painful bladder syndrome","volume":"295","author":"Patnaik","year":"2017","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.ophtha.2019.10.036_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0090-4295(97)00110-6","article-title":"Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis","volume":"50","author":"Hwang","year":"1997","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ophtha.2019.10.036_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bju.14399","article-title":"Guideline of guidelines: bladder pain syndrome","volume":"122","author":"Malde","year":"2018","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ophtha.2019.10.036_bib8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.juro.2014.09.036","article-title":"Pentosan polysulfate sodium for treatment of interstitial cystitis\/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study","volume":"193","author":"Nickel","year":"2015","journal-title":"J Urology"},{"issue":"7","key":"10.1016\/j.ophtha.2019.10.036_bib9","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2018.12.037","article-title":"Re: Pearce et\u00a0al: Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium (Ophthalmology. 2018;125:1793\u20131802","volume":"126","author":"Greenlee","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2019.10.036_bib11","series-title":"Regenerative Biology of the Eye","first-page":"49","article-title":"The regenerative potential of the vertebrate retina: lessons from the zebrafish","author":"Ng","year":"2014"},{"issue":"1","key":"10.1016\/j.ophtha.2019.10.036_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030365","article-title":"Fgf signaling is required for photoreceptor maintenance in the adult zebrafish retina","volume":"7","author":"Hochmann","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ophtha.2019.10.036_bib13","doi-asserted-by":"crossref","first-page":"16052","DOI":"10.18632\/oncotarget.14109","article-title":"Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application","volume":"8","author":"Chae","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ophtha.2019.10.036_bib14","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019322110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019322110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:07:54Z","timestamp":1758982074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642019322110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0161642019322110"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.10.036","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentosan Polysulfate Sodium Exposure and Drug-Induced Maculopathy in Commercially Insured Patients in the United States","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.10.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}